{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T10:53:39.764018+00:00","published_at":"2026-09-21T14:38:04.135271+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1jqqerq1jcwfzs","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-13","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:leon-hooftman","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:67b2f1fe27d37edf5cc4af25f8cd39bc8d26301aa117d75c9063f76cd608c739"],"summary":"Leon Hooftman executive of Barinthus Biotherapeutics plc., effective 2026-03-13.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14u11yblv7g2v","event_type":"CEO_CHANGED","effective_at":"2026-03-13","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:william-enright","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:46e295a328cf3b81eb2f1cfa405d934f6fedad46ec9a7848cbe67b575270fcec"],"summary":"William Enright executive of Barinthus Biotherapeutics plc., effective 2026-03-13.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1336yrq6hzubq","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:anne-m-phillips","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Anne M. Phillips seat on Barinthus Biotherapeutics plc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1jzi1o31bab7cn","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:joseph-c-scheeren","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Joseph C. Scheeren seat on Barinthus Biotherapeutics plc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1y76fhq1kpk89w","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:karen-t-dawes","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Karen T. Dawes seat on Barinthus Biotherapeutics plc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:pivlievhl5bg","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:committee:barinthus-biotherapeutics-plc:audit-nominating-and-governance","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Audit; Nominating and Governance committee of Barinthus Biotherapeutics plc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:156nxcbehrq5r","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:karen-t-dawes","alpha:committee:barinthus-biotherapeutics-plc:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Karen T. Dawes member of Audit; Nominating and Governance, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18p79ayh6rmd2","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:committee:barinthus-biotherapeutics-plc:compensation-chair","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Compensation · Chair committee of Barinthus Biotherapeutics plc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:kaybpm1p96glm","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:anne-m-phillips","alpha:committee:barinthus-biotherapeutics-plc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Anne M. Phillips member of Compensation · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fzxb4vzcxc8v","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:committee:barinthus-biotherapeutics-plc:compensation-nominating-and-governance","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Compensation; Nominating and Governance committee of Barinthus Biotherapeutics plc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ehh9i9ecd67l","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:joseph-c-scheeren","alpha:committee:barinthus-biotherapeutics-plc:compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Joseph C. Scheeren member of Compensation; Nominating and Governance, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:48yvc211g1tw8","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:alex-hammacher","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Alex Hammacher seat on Barinthus Biotherapeutics plc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1en22dr1pby29v","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:william-enright","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"William Enright seat on Barinthus Biotherapeutics plc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:159ryovrmh9jn","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:pierre-a-morgon","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Pierre A. Morgon seat on Barinthus Biotherapeutics plc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:u4aap9yxfbvb","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:robin-wright","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Richard A. Wright seat on Barinthus Biotherapeutics plc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:n1y17j1bfdxwb","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:committee:barinthus-biotherapeutics-plc:audit-chair-compensation","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Audit · Chair; Compensation committee of Barinthus Biotherapeutics plc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bthuzvn9e47z","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:robin-wright","alpha:committee:barinthus-biotherapeutics-plc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Richard A. Wright member of Audit · Chair; Compensation, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zw0u13zl19kz","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:committee:barinthus-biotherapeutics-plc:audit-nominating-and-governance-chair","alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Audit; Nominating and Governance · Chair committee of Barinthus Biotherapeutics plc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bxfvmshiqd48","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-09-21T14:38:04.135271+00:00","subject_ids":["alpha:person:pierre-a-morgon","alpha:committee:barinthus-biotherapeutics-plc:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663"],"summary":"Pierre A. Morgon member of Audit; Nominating and Governance · Chair, effective 2018-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:5","subject_id":"alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alex-hammacher","object_label":"Alex Hammacher","object_source_name_forms":[],"value":"Alex Hammacher: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alex-hammacher","name":"Alex Hammacher"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-09-21T14:38:04.135271+00:00","sources":[{"id":"alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Barinthus Biotherapeutics plc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818525000027/brns-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-09-21T14:38:04.135271+00:00","reviewed_at":"2026-09-21T14:38:04.135271+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:6","subject_id":"alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:anne-m-phillips","object_label":"Anne M. Phillips","object_source_name_forms":[],"value":"Anne M. Phillips: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:anne-m-phillips","name":"Anne M. Phillips"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-09-21T14:38:04.135271+00:00","sources":[{"id":"alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Barinthus Biotherapeutics plc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818525000027/brns-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-09-21T14:38:04.135271+00:00","reviewed_at":"2026-09-21T14:38:04.135271+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:7","subject_id":"alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:joseph-c-scheeren","object_label":"Joseph C. Scheeren","object_source_name_forms":[],"value":"Joseph C. Scheeren: Director, Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:joseph-c-scheeren","name":"Joseph C. Scheeren"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-09-21T14:38:04.135271+00:00","sources":[{"id":"alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Barinthus Biotherapeutics plc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818525000027/brns-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-09-21T14:38:04.135271+00:00","reviewed_at":"2026-09-21T14:38:04.135271+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:8","subject_id":"alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:karen-t-dawes","object_label":"Karen T. Dawes","object_source_name_forms":[],"value":"Karen T. Dawes: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:karen-t-dawes","name":"Karen T. Dawes"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-09-21T14:38:04.135271+00:00","sources":[{"id":"alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Barinthus Biotherapeutics plc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818525000027/brns-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-09-21T14:38:04.135271+00:00","reviewed_at":"2026-09-21T14:38:04.135271+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:9","subject_id":"alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:pierre-a-morgon","object_label":"Pierre A. Morgon","object_source_name_forms":[],"value":"Pierre A. Morgon: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:pierre-a-morgon","name":"Pierre A. Morgon"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-09-21T14:38:04.135271+00:00","sources":[{"id":"alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Barinthus Biotherapeutics plc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818525000027/brns-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-09-21T14:38:04.135271+00:00","reviewed_at":"2026-09-21T14:38:04.135271+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:10","subject_id":"alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:robin-wright","object_label":"Richard A. Wright","object_source_name_forms":[],"value":"Richard A. Wright: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:robin-wright","name":"Richard A. Wright"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-09-21T14:38:04.135271+00:00","sources":[{"id":"alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Barinthus Biotherapeutics plc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818525000027/brns-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-09-21T14:38:04.135271+00:00","reviewed_at":"2026-09-21T14:38:04.135271+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:11","subject_id":"alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:william-enright","object_label":"William Enright","object_source_name_forms":[],"value":"William Enright: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:william-enright","name":"William Enright"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-09-21T14:38:04.135271+00:00","sources":[{"id":"alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Barinthus Biotherapeutics plc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818525000027/brns-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-09-21T14:38:04.135271+00:00","reviewed_at":"2026-09-21T14:38:04.135271+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:12","subject_id":"alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:leon-hooftman","object_label":"Leon Hooftman","object_source_name_forms":[],"value":"Leon Hooftman: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:leon-hooftman","name":"Leon Hooftman"},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-13","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-13","valid_to":null,"recorded_at":"2026-09-21T14:38:04.135271+00:00","sources":[{"id":"alpha:projection-evidence:document:67b2f1fe27d37edf5cc4af25f8cd39bc8d26301aa117d75c9063f76cd608c739","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BRNS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818526000012/brns-20251231.htm","source_date":"2026-03-13T00:00:00+00:00","retrieved_at":"2026-05-15T23:53:27.42554+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-13T00:00:00+00:00","effective_from":"2026-03-13","effective_until":null,"observed_at":"2026-09-21T14:38:04.135271+00:00","reviewed_at":"2026-09-21T14:38:04.135271+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:abcf40a6-db57-4b43-8d38-41752e9d030e:leadership_role:13","subject_id":"alpha:company:abcf40a6-db57-4b43-8d38-41752e9d030e","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:william-enright","object_label":"William Enright","object_source_name_forms":[],"value":"William Enright: Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:william-enright","name":"William Enright"},"title":"Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-13","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-13","valid_to":null,"recorded_at":"2026-09-21T14:38:04.135271+00:00","sources":[{"id":"alpha:projection-evidence:document:46e295a328cf3b81eb2f1cfa405d934f6fedad46ec9a7848cbe67b575270fcec","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BRNS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818526000012/brns-20251231.htm","source_date":"2026-03-13T00:00:00+00:00","retrieved_at":"2026-05-15T23:53:26.95393+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-13T00:00:00+00:00","effective_from":"2026-03-13","effective_until":null,"observed_at":"2026-09-21T14:38:04.135271+00:00","reviewed_at":"2026-09-21T14:38:04.135271+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:14ee55b5a20a278bc7d83abbcd03b5ac2f471eff57463cdb0e66e674fbc32663","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Barinthus Biotherapeutics plc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818525000027/brns-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:67b2f1fe27d37edf5cc4af25f8cd39bc8d26301aa117d75c9063f76cd608c739","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BRNS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818526000012/brns-20251231.htm","source_date":"2026-03-13T00:00:00+00:00","retrieved_at":"2026-05-15T23:53:27.42554+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:46e295a328cf3b81eb2f1cfa405d934f6fedad46ec9a7848cbe67b575270fcec","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BRNS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818526000012/brns-20251231.htm","source_date":"2026-03-13T00:00:00+00:00","retrieved_at":"2026-05-15T23:53:26.95393+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.896,"cross_source_agreement":0.75,"temporal_completeness":0.5},"diagnostics":{"published_claims":25,"factual_claims":25,"claims_with_linked_evidence":25,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":18,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-09-21T14:38:04.135271+00:00","observed_at":"2026-09-21T14:38:04.135271+00:00","reviewed_at":"2026-09-21T14:38:04.135271+00:00","verified_at":"2026-09-21T14:38:04.135271+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":25,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/barinthus-biotherapeutics-plc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/barinthus-biotherapeutics-plc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}